{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/161327507"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "ts.Allegiance targets markets having clearly identified product deficiencies and dissatisfied consumers afflicted with common diseases and conditions including Alzheimer's, dementia, diabetes and inflammatory skin conditions, Allegiance obtains regulatory approval and patents for these unique compounds and formulations, for licensing, and royalty revenues.http://www.allegianceequity.com/For furthe" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "yahoo.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/193012238"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/161327507" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/218851747"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/161327507"] } } }
